About this Journal Submit a Manuscript Table of Contents
ISRN Immunology
Volume 2012 (2012), Article ID 963879, 11 pages
http://dx.doi.org/10.5402/2012/963879
Review Article

New Aspects in Immunopathology of Mycobacterium tuberculosis

1Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Division of Pharmacology and Pathophysiology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Sciences, Utrecht University, Utrecht, The Netherlands
3Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University, Tehran, Iran

Received 4 January 2012; Accepted 24 January 2012

Academic Editor: L. Szereday

Copyright © 2012 E. Mortaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. W. Schluger, “Recent advances in our understanding of human host responses to tuberculosis,” Respiratory Research, vol. 2, no. 3, pp. 157–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, “Global tuberculosis control 2010,” WHO Report 201, World Health Organization, Geneva, Switzerlands.
  3. World Health Organization, “Global tuberculosis control,” WHO Report WHO/CDS/TB/2001.287, World Health Organization, Geneva, Switzerlands, 2001.
  4. S. Malik and E. Schurr, “Genetic susceptibility to tuberculosis,” Clinical Chemistry and Laboratory Medicine, vol. 40, no. 9, pp. 863–868, 2002. View at Scopus
  5. J. Kleinnijenhuis, M. Oosting, L. A.B. Joosten, M. G. Netea, and R. Van Crevel, “Innate immune recognition of Mycobacterium tuberculosis,” Clinical and Developmental Immunology, vol. 2011, Article ID 405310, 12 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  6. H. Saiga, Y. Shimada, and K. Takeda, “Innate immune effectors in mycobacterial infection,” Clinical and Developmental Immunology, vol. 2011, Article ID 347594, 8 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  7. A. Mortellaro, L. Robinson, and R. C. Paola, “Spotlight on mycobacteria and dendritic cells: will novel targets to fight tuberculosis emerge?” EMBO Molecular Medicine, vol. 1, no. 1, pp. 19–29, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. N. W. Schluger and W. N. Rom, “The host immune response to tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 3, pp. 679–691, 1998. View at Scopus
  9. R. L. Coffman and S. Romagnani, Redirection of Th1 and Th2 Responses, Springer, Berlin, Germany, 1999.
  10. T. R. Mosmann and S. Sad, “The expanding universe of T-cell subsets: Th1, Th2 and more,” Immunology Today, vol. 17, no. 3, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Romagnani and T. Mosmann, “Human T(H)1 and T(H)2 subsets: doubt no more,” Immunology Today, vol. 12, no. 8, pp. 256–257, 1991. View at Scopus
  12. P. A. Sieling and R. L. Modlin, “Cytokine patterns at the site of mycobacterial infection,” Immunobiology, vol. 191, no. 4-5, pp. 378–387, 1994. View at Scopus
  13. Y. Suzuki, F. K. Conley, and J. S. Remington, “Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice,” Journal of Immunology, vol. 143, no. 6, pp. 2045–2050, 1989. View at Scopus
  14. H. Kornfeld, G. Mancino, and V. Colizzi, “The role of macrophage cell death in tuberculosis,” Cell Death and Differentiation, vol. 6, no. 1, pp. 71–78, 1999. View at Scopus
  15. M. Niederweis, O. Danilchanka, J. Huff, C. Hoffmann, and H. Engelhardt, “Mycobacterial outer membranes: in search of proteins,” Trends in Microbiology, vol. 18, no. 3, pp. 109–116, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Ahmad, “Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection,” Clinical and Developmental Immunology, vol. 2011, Article ID 814943, 17 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  17. S. Brighenti and J. Andersson, “Induction and regulation of CD8+ cytolytic T cells in human tuberculosis and HIV infection,” Biochemical and Biophysical Research Communications, vol. 396, no. 1, pp. 50–57, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Stenger, “Cytolytic T cells in the immune response to Mycobacterium tuberculosis,” Scandinavian Journal of Infectious Diseases, vol. 33, no. 7, pp. 483–487, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. L. F. Barker, M. J. Brennan, P. K. Rosenstein, and J. C. Sadoff, “Tuberculosis vaccine research: the impact of immunology,” Current Opinion in Immunology, vol. 21, no. 3, pp. 331–338, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. R. J. North and Y. J. Jung, “Immunity to tuberculosis,” Annual Review of Immunology, vol. 22, pp. 599–623, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. H. E. Kaufmann, “Protection against tuberculosis: cytokines, T cells, and macrophages,” Annals of the Rheumatic Diseases, vol. 61, supplement 2, pp. 54–58, 2002. View at Scopus
  22. S. N. M. Hanif, R. Al-Attiyah, and A. S. Mustafa, “Species-specific antigenic Mycobacterium tuberculosis proteins tested by delayed-type hypersensitivity response,” International Journal of Tuberculosis and Lung Disease, vol. 14, no. 4, pp. 489–494, 2010. View at Scopus
  23. J. L. Flynn, J. Chan, and P. L. Lin, “Macrophages and control of granulomatous inflammation in tuberculosis,” Mucosal Immunology, vol. 4, no. 3, pp. 271–278, 2011. View at Publisher · View at Google Scholar · View at PubMed
  24. H. P. Gideon and J. L. Flynn, “Latent tuberculosis: what the host "sees"?” Immunologic Research, vol. 50, no. 2-3, pp. 202–212, 2011. View at Publisher · View at Google Scholar · View at PubMed
  25. S. H. E. Kaufmann, “The macrophage in tuberculosis: sinner of saint? The T cell decides,” Pathobiology, vol. 59, no. 3, pp. 153–155, 1991. View at Scopus
  26. J. A. Philips and J. D. Ernst, “Tuberculosis pathogenesis and immunity,” Annual Review of Pathology, vol. 7, pp. 353–384, 2012. View at Publisher · View at Google Scholar · View at PubMed
  27. D. Sud, C. Bigbee, J. L. Flynn, and D. E. Kirschner, “Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 176, no. 7, pp. 4296–4314, 2006. View at Scopus
  28. J. Turner and H. M. Dockrell, “Stimulation of human peripheral blood mononuclear cells with live mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro,” Immunology, vol. 87, no. 3, pp. 339–342, 1996. View at Scopus
  29. D. H. Canaday, R. J. Wilkinson, Q. Li, C. V. Harding, R. F. Silver, and W. H. Boom, “CD4+ and CD8+ T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism,” Journal of Immunology, vol. 167, no. 5, pp. 2734–2742, 2001. View at Scopus
  30. T. Mutis, Y. E. Cornelisse, and T. H. M. Ottenhoff, “Mycobacteria induce CD4+ T cells that are cytotoxic and display Th1-like cytokine secretion profile: heterogeneity in cytotoxic activity and cytokine secretion levels,” European Journal of Immunology, vol. 23, no. 9, pp. 2189–2195, 1993. View at Scopus
  31. F. Dieli, M. Troye-Blomberg, J. Ivanyi et al., “Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis,” European Journal of Immunology, vol. 30, no. 5, pp. 1512–1519, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. C. H. Ladel, C. Blum, A. Dreher, K. Reifenberg, and S. H. E. Kaufmann, “Protective role of γ/δ T cells and α/β T cells in tuberculosis,” European Journal of Immunology, vol. 25, no. 10, pp. 2877–2881, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. F. J. Culley, “Natural killer cells in infection and inflammation of the lung,” Immunology, vol. 128, no. 2, pp. 151–163, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. A. Raja, “Immunology of tuberculosis,” Indian Journal of Medical Research, vol. 120, no. 4, pp. 213–232, 2004. View at Scopus
  35. X. Chen, B. Zhou, M. Li et al., “CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease,” Clinical Immunology, vol. 123, no. 1, pp. 50–59, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani, “Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 803–810, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. R. Ribeiro-Rodrigues, T. Resende Co, R. Rojas et al., “A role for CD4+ CD25+ T cells in regulation of the immune response during human tuberculosis,” Clinical and Experimental Immunology, vol. 144, no. 1, pp. 25–34, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. S. A. Khader, J. E. Pearl, K. Sakamoto et al., “IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available,” Journal of Immunology, vol. 175, no. 2, pp. 788–795, 2005. View at Scopus
  39. S. Sergejeva, S. Ivanov, J. Lötvall, and A. Lindén, “Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 3, pp. 248–253, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. J. K. Kolls and A. Lindén, “Interleukin-17 family members and inflammation,” Immunity, vol. 21, no. 4, pp. 467–476, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. Miyamoto, O. Prause, M. Sjöstrand, M. Laan, J. Lötvall, and A. Lindén, “Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways,” Journal of Immunology, vol. 170, no. 9, pp. 4665–4672, 2003.
  42. M. A. Stark, Y. Huo, T. L. Burcin, M. A. Morris, T. S. Olson, and K. Ley, “Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17,” Immunity, vol. 22, no. 3, pp. 285–294, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. S. Sergejeva, S. Ivanov, J. Lötvall, and A. Lindén, “Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 3, pp. 248–253, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. S. A. Khader, G. K. Bell, J. E. Pearl et al., “IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge,” Nature Immunology, vol. 8, no. 4, pp. 369–377, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. F. Shen, Z. Hu, J. Goswami, and S. L. Gaffen, “Identification of common transcriptional regulatory elements in interleukin-17 target genes,” Journal of Biological Chemistry, vol. 281, no. 34, pp. 24138–24148, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. J. Lee, M. Hartman, and H. Kornfeld, “Macrophage apoptosis in tuberculosis,” Yonsei Medical Journal, vol. 50, no. 1, pp. 1–11, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. L. S. Schlesinger, “Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors,” Journal of Immunology, vol. 150, no. 7, pp. 2920–2930, 1993. View at Scopus
  48. S. Zimmerli, S. Edwards, and J. D. Ernst, “Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages,” American Journal of Respiratory Cell and Molecular Biology, vol. 15, no. 6, pp. 760–770, 1996. View at Scopus
  49. P. Schierloh, N. Yokobori, M. Alemán et al., “Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy,” Infection and Immunity, vol. 75, no. 11, pp. 5325–5337, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. A. J. Gehring, R. E. Rojas, D. H. Canaday, D. L. Lakey, C. V. Harding, and W. H. Boom, “The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through toll-like receptor 2,” Infection and Immunity, vol. 71, no. 8, pp. 4487–4497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. F. C. Lin, Y. C. Chen, F. J. Chen, and S. C. Chang, “Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions,” Clinical Immunology, vol. 116, no. 2, pp. 166–173, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. K. Rohde, R. M. Yates, G. E. Purdy, and D. G. Russell, “Mycobacterium tuberculosis and the environment within the phagosome,” Immunological Reviews, vol. 219, no. 1, pp. 37–54, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. D. L. Clemens and M. A. Horwitz, “Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited,” Journal of Experimental Medicine, vol. 181, no. 1, pp. 257–270, 1995. View at Publisher · View at Google Scholar · View at Scopus
  54. I. P. Fairbairn, “Macrophage apoptosis in host immunity to mycobacterial infections,” Biochemical Society Transactions, vol. 32, no. 3, pp. 496–498, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. C. de Chastellier, “The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages,” Immunobiology, vol. 214, no. 7, pp. 526–542, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. N. Ismail, J. P. Olano, H. M. Feng, and D. H. Walker, “Current status of immune mechanisms of killing of intracellular microorganims,” FEMS Microbiology Letters, vol. 207, no. 2, pp. 111–120, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. G. Gutierrez, S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic, “Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages,” Cell, vol. 119, no. 6, pp. 753–766, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. G. E. Purdy and D. G. Russell, “Lysosomal ubiquitin and the demise of Mycobacterium tuberculosis,” Cellular Microbiology, vol. 9, no. 12, pp. 2768–2774, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. J. Lee, H. G. Remold, M. H. Ieong, and H. Kornfeld, “Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway,” Journal of Immunology, vol. 176, no. 7, pp. 4267–4274, 2006. View at Scopus
  60. J. S. Park, M. H. Tamayo, M. Gonzalez-Juarrero, I. M. Orme, and D. J. Ordway, “Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages,” Journal of Leukocyte Biology, vol. 79, no. 1, pp. 80–86, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. J. Hinchey, S. Lee, B. Y. Jeon et al., “Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis,” Journal of Clinical Investigation, vol. 117, no. 8, pp. 2279–2288, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. D. M. Lowe, P. S. Redford, R. J. Wilkinson, A. O'Garra, and A. R. Martineau, “Neutrophils in tuberculosis: friend or foe?” Trends in Immunology, vol. 33, no. 1, pp. 14–25, 2012. View at Publisher · View at Google Scholar · View at PubMed
  63. K. F. Law, J. Jagirdar, M. D. Weiden, M. Bodkin, and W. N. Rom, “Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 4, pp. 1377–1384, 1996. View at Scopus
  64. V. B. Antony, S. A. Sahn, R. N. Harada, and J. E. Repine, “Lung repair and granuloma formation. Tubercle bacilli stimulated neutrophils release chemotactic factors for monocytes,” Chest, vol. 83, no. 5, 1983. View at Scopus
  65. R. Appelberg and M. T. Silva, “T cell-dependent chronic neutrophilia during mycobacterial infections,” Clinical and Experimental Immunology, vol. 78, no. 3, pp. 478–483, 1989. View at Scopus
  66. J. Pedrosa, B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper, “Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice,” Infection and Immunity, vol. 68, no. 2, pp. 577–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Hartmann, R. Becker, C. Franzen et al., “Phagocytosis and killing of Mycobacterium avium complex by human neutrophils,” Journal of Leukocyte Biology, vol. 69, no. 3, pp. 397–404, 2001. View at Scopus
  68. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. R. M. Steinman, “Dendritic cells,” in Fundamental Immunology, W. E. Paul , Ed., p. 547, Lippincott-Raven, New York, NY, USA, 1999.
  70. R. E. Tascon, C. S. Soares, S. Ragno, E. Stavropoulos, E. M. A. Hirst, and M. J. Colston, “Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice,” Immunology, vol. 99, no. 3, pp. 473–480, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Tian, J. Woodworth, M. Sköld, and S. M. Behar, “In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection,” Journal of Immunology, vol. 175, no. 5, pp. 3268–3272, 2005. View at Scopus
  72. A. A. Chackerian, J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar, “Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity,” Infection and Immunity, vol. 70, no. 8, pp. 4501–4509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. I. R. Humphreys, G. R. Stewart, D. J. Turner et al., “A role for dendritic cells in the dissemination of mycobacterial infection,” Microbes and Infection, vol. 8, no. 5, pp. 1339–1346, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. S. A. Khader, J. E. Pearl, K. Sakamoto et al., “IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available,” Journal of Immunology, vol. 175, no. 2, pp. 788–795, 2005. View at Scopus
  75. E. Lockhart, A. M. Green, and J. L. Flynn, “IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 177, no. 7, pp. 4662–4669, 2006. View at Scopus
  76. T. M. Wozniak, A. A. Ryan, J. A. Triccas, and W. J. Britton, “Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection,” Infection and Immunity, vol. 74, no. 1, pp. 557–565, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. R. C.M. Ryan, M. P. O'Sullivan, and J. Keane, “Mycobacterium tuberculosis infection induces non-apoptotic cell death of human dendritic cells,” BMC Microbiology, vol. 11, no. 1, p. 237, 2011. View at Publisher · View at Google Scholar · View at PubMed
  78. G. Pier, J. Lyczak, and L. Wetzler, “Cell mediated immunity,” in Immunology, Infection, and Immunity, ASM Press, Washington, DC, USA, 2004.
  79. J. Harris, S. A. De Haro, S. S. Master et al., “T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis,” Immunity, vol. 27, no. 3, pp. 505–517, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. I. Vergne, S. Singh, E. Roberts et al., “Autophagy in immune defense against Mycobacterium tuberculosis,” Autophagy, vol. 2, no. 3, pp. 175–178, 2006. View at Scopus
  81. G. Tully, C. Kortsik, H. Höhn et al., “Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 174, no. 4, pp. 2174–2184, 2005. View at Scopus
  82. L. Szereday, Z. Baliko, and J. Szekeres-Bartho, “γ/δ T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy,” Clinical and Experimental Immunology, vol. 131, no. 2, pp. 287–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. L. E. Bermudez and J. Goodman, “Mycobacterium tuberculosis invades and replicates within type II alveolar cells,” Infection and Immunity, vol. 64, no. 4, pp. 1400–1406, 1996. View at Scopus
  84. R. Teitelbaum, W. Schubert, L. Gunther et al., “The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis,” Immunity, vol. 10, no. 6, pp. 641–650, 1999. View at Publisher · View at Google Scholar · View at Scopus
  85. S. M. Mirsaeidi, M. R. Masjedi, S. D. Mansouri, and A. A. Velayati, “Tuberculosis of the breast: report of 4 clinical cases and literature review,” Eastern Mediterranean Health Journal, vol. 13, no. 3, pp. 670–676, 2007. View at Scopus
  86. G. J. Wise, “Urinary tuberculosis: modern issues,” Current Urology Reports, vol. 10, no. 4, pp. 313–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Keane, S. Gershon, R. P. Wise et al., “Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent,” New England Journal of Medicine, vol. 345, no. 15, pp. 1098–1104, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  88. D. A. Lammas, J. L. Casanova, and D. S. Kumararatne, “Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-γ) pathway,” Clinical and Experimental Immunology, vol. 121, no. 3, pp. 417–425, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. F. L. Van De Veerdonk, A. C. Teirlinck, J. Kleinnijenhuis et al., “Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1,” Journal of Leukocyte Biology, vol. 88, no. 2, pp. 227–232, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. D. Gupta, S. Sharma, J. Singhal, A. T. Satsangi, C. Antony, and K. Natarajan, “Suppression of TLR2-induced il-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium tuberculosis antigens expressed inside macrophages during the course of infection,” Journal of Immunology, vol. 184, no. 10, pp. 5444–5455, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. G. A. W. Rook, “Th2 cytokines in susceptibility to tuberculosis,” Current Molecular Medicine, vol. 7, no. 3, pp. 327–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Hernández-Pando, H. Orozcoe, A. Sampieri et al., “Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis,” Immunology, vol. 89, no. 1, pp. 26–33, 1996. View at Scopus
  93. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway, “A human homologue of the Drosophila toll protein signals activation of adaptive immunity,” Nature, vol. 388, no. 6640, pp. 394–397, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. S. L. Doyle and L. A. J. O'Neill, “Toll-like receptors: from the discovery of NFκB to new insights into transcriptional regulations in innate immunity,” Biochemical Pharmacology, vol. 72, no. 9, pp. 1102–1113, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. L. Gan and L. Li, “Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity,” Immunologic Research, vol. 35, no. 3, pp. 295–302, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. S. Akira and H. Hemmi, “Recognition of pathogen-associated molecular patterns by TLR family,” Immunology Letters, vol. 85, no. 2, pp. 85–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. E. A. Kurt-Jones, L. Popova, L. Kwinn et al., “Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus,” Nature Immunology, vol. 1, no. 5, pp. 398–401, 2000. View at Scopus
  101. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  102. S. Akira and H. Hemmi, “Recognition of pathogen-associated molecular patterns by TLR family,” Immunology Letters, vol. 85, no. 2, pp. 85–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. E. A. Kurt-Jones, L. Popova, L. Kwinn et al., “Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus,” Nature Immunology, vol. 1, no. 5, pp. 398–401, 2000. View at Scopus
  104. S. Khare, N. Luc, A. Dorfleutner, and C. Stehlik, “Inflammasomes and their activation,” Critical Reviews in Immunology, vol. 30, no. 5, pp. 463–487, 2010. View at Scopus
  105. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  106. H. Kumar, T. Kawai, and S. Akira, “Toll-like receptors and innate immunity,” Biochemical and Biophysical Research Communications, vol. 388, no. 4, pp. 621–625, 2009. View at Publisher · View at Google Scholar · View at PubMed
  107. M. Yamamoto and K. Takeda, “Current views of toll-like receptor signaling pathways,” Gastroenterology Research and Practice, vol. 2010, Article ID 240365, 8 pages, 2010. View at Publisher · View at Google Scholar · View at PubMed
  108. T. Kawai and S. Akira, “Toll-like receptors and their crosstalk with other innate receptors in infection and immunity,” Immunity, vol. 34, no. 5, pp. 637–650, 2011. View at Publisher · View at Google Scholar · View at PubMed
  109. H. Kumar, T. Kawai, and S. Akira, “Pathogen recognition by the innate immune system,” International Reviews of Immunology, vol. 30, no. 1, pp. 16–34, 2011. View at Publisher · View at Google Scholar · View at PubMed
  110. E. Mortaz, I. M. Adcock, K. Ito, A. D. Kraneveld, F. P. Nijkamp, and G. Folkerts, “Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor,” European Respiratory Journal, vol. 36, no. 5, pp. 1143–1154, 2010. View at Publisher · View at Google Scholar · View at PubMed
  111. J. C. Leemans, N. P. Juffermans, S. Florquin et al., “Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice,” Journal of Immunology, vol. 166, no. 7, pp. 4604–4611, 2001. View at Scopus
  112. V. Quesniaux, C. Fremond, M. Jacobs et al., “Toll-like receptor pathways in the immune responses to mycobacteria,” Microbes and Infection, vol. 6, no. 10, pp. 946–959, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  113. C. H. Ladel, C. Blum, A. Dreher, K. Reifenberg, M. Kopf, and S. H. E. Kaufmann, “Lethal tuberculosis in interleukin-6-deficient mutant mice,” Infection and Immunity, vol. 65, no. 11, pp. 4843–4849, 1997. View at Scopus
  114. A. G. D. Bean, D. R. Roach, H. Briscoe et al., “Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin,” Journal of Immunology, vol. 162, no. 6, pp. 3504–3511, 1999. View at Scopus
  115. H. Yamada, S. Mizumo, R. Horai, Y. Iwakura, and I. Sugawara, “Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice,” Laboratory Investigation, vol. 80, no. 5, pp. 759–767, 2000. View at Scopus
  116. C. M. Fremond, V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel, “Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1790–1799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  117. C. A. Scanga, A. Bafica, C. G. Feng, A. W. Cheever, S. Hieny, and A. Sher, “MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired th1 cytokine and nitric oxide synthase 2 expression,” Infection and Immunity, vol. 72, no. 4, pp. 2400–2404, 2004. View at Publisher · View at Google Scholar
  118. D. M. Shin, B. Y. Jeon, H. M. Lee et al., “Mycobacterium tuberculosis eis regulates autophagy, inflammation, and cell death through redox-dependent signaling,” PLoS Pathogens, vol. 6, no. 12, article e1001230, 2010. View at Publisher · View at Google Scholar · View at PubMed
  119. H. M. Lee, D. M. Shin, K. K. Kim, J. S. Lee, T. H. Paik, and E. K. Jo, “Roles of reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of Mycobacterium tuberculosis,” Journal of Clinical Immunology, vol. 29, no. 1, pp. 46–56, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  120. T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton, “Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis,” Journal of Immunology, vol. 163, no. 7, pp. 3920–3927, 1999. View at Scopus
  121. I. Sugawara, H. Yamada, C. Li, S. Mizuno, O. Takeuchi, and S. Akira, “Mycobacterial infection in TLR2 and TLR6 knockout mice,” Microbiology and Immunology, vol. 47, no. 5, pp. 327–336, 2003.
  122. M. B. Drennan, D. Nicolle, V. J.F. Quesniaux et al., “Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection,” American Journal of Pathology, vol. 164, no. 1, pp. 49–57, 2004.
  123. B. Abel, N. Thieblemont, V. J. F. Quesniaux et al., “Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice,” Journal of Immunology, vol. 169, no. 6, pp. 3155–3162, 2002. View at Scopus
  124. J. Branger, S. Knapp, S. Weijer et al., “Role of toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice,” Infection and Immunity, vol. 72, no. 2, pp. 788–794, 2004. View at Publisher · View at Google Scholar · View at Scopus
  125. A. A. Chackerian, T. V. Perera, and S. M. Behar, “Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis,” Infection and Immunity, vol. 69, no. 4, pp. 2666–2674, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  126. N. Reiling, C. Hölscher, A. Fehrenbach et al., “Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis,” Journal of Immunology, vol. 169, no. 7, pp. 3480–3484, 2002.
  127. A. B. Kamath, J. Alt, H. Debbabi, and S. M. Behar, “Toll-like receptor 4-defective C3H/Hej mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis,” Infection and Immunity, vol. 71, no. 7, pp. 4112–4118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. S. R. Krutzik, M. T. Ochoa, P. A. Sieling et al., “Activation and regulation of Toll-like receptors 2 and 1 in human leprosy,” Nature Medicine, vol. 9, no. 5, pp. 525–532, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  129. L. Alexopoulou, V. Thomas, M. Schnare et al., “Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice,” Nature Medicine, vol. 8, no. 8, pp. 878–884, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  130. N. C. Arbour, E. Lorenz, B. C. Schutte et al., “TLR4 mutations are associated with endotoxin hyporesponsiveness in humans,” Nature Genetics, vol. 25, no. 2, pp. 187–191, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  131. T. J. Kang, S. B. Lee, and G. T. Chae, “A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy,” Cytokine, vol. 20, no. 2, pp. 56–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. E. Lorenz, J. P. Mira, K. L. Cornish, N. C. Arbour, and D. A. Schwartz, “A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection,” Infection and Immunity, vol. 68, no. 11, pp. 6398–6401, 2000. View at Publisher · View at Google Scholar · View at Scopus
  133. G. Fenhalls, G. R. Squires, L. Stevens-Muller et al., “Associations between toll-like receptors and interleukin-4 in the lungs of patients with tuberculosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 1, pp. 28–38, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  134. G. A. Rook, K. Dheda, and A. Zumla, “Opinion: immune responses to tuberculosis in developing countries: implications for new vaccines,” Nature Reviews Immunology, vol. 5, pp. 661–667, 2005.
  135. C. Garlanda, D. Di Liberto, A. Vecchi et al., “Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling,” Journal of Immunology, vol. 179, no. 5, pp. 3119–3125, 2007. View at Scopus
  136. J. P. Y. Ting, R. C. Lovering, E. S. Alnemri et al., “The NLR Gene family: a standard nomenclature,” Immunity, vol. 28, no. 3, pp. 285–287, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  137. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  138. I. C. Koo, C. Wang, S. Raghavan, J. H. Morisaki, J. S. Cox, and E. J. Brown, “ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection,” Cellular Microbiology, vol. 10, no. 9, pp. 1866–1878, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  139. S. S. Master, S. K. Rampini, A. S. Davis et al., “Mycobacterium tuberculosis prevents inflammasome activation,” Cell Host and Microbe, vol. 3, no. 4, pp. 224–232, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  140. B. B. Mishra, P. Moura-Alves, A. Sonawane et al., “Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome,” Cellular Microbiology, vol. 12, no. 8, pp. 1046–1063, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  141. J. Chan, Y. Xing, R. S. Magliozzo, and B. R. Bloom, “Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages,” Journal of Experimental Medicine, vol. 175, no. 4, pp. 1111–1122, 1992. View at Scopus
  142. L. A. H. Van Pinxteren, J. P. Cassidy, B. H. C. Smedegaard, E. M. Agger, and P. Andersen, “Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells,” European Journal of Immunology, vol. 30, no. 12, pp. 3689–3698, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. T. Ulrichs and S. H. E. Kaufmann, “New insights into the function of granulomas in human tuberculosis,” Journal of Pathology, vol. 208, no. 2, pp. 261–269, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  144. I. Sugawara, H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira, “Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18- gene-disrupted mice,” Infection and Immunity, vol. 67, no. 5, pp. 2585–2589, 1999. View at Scopus
  145. I. Sugawara, H. Yamada, S. Hua, and S. Mizuno, “Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection,” Microbiology and Immunology, vol. 45, no. 11, pp. 743–750, 2001.
  146. N. P. Juffermans, S. Florquin, L. Camoglio et al., “Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis,” Journal of Infectious Diseases, vol. 182, no. 3, pp. 902–908, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  147. K. D. Mayer-Barber, D. L. Barber, K. Shenderov et al., “Cutting edge: caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo,” Journal of Immunology, vol. 184, no. 7, pp. 3326–3330, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  148. E. McElvania Tekippe, I. C. Allen, P. D. Hulseberg et al., “Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1,” PloS one, vol. 5, no. 8, p. e12320, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus